HIGGINS ARTHUR J - 13 Nov 2024 Form 4 Insider Report for ECOLAB INC. (ECL)

Role: Director
Signature: /s/ David F. Duvick, as Attorney-in-Fact for Arthur J. Higgins
Issuer symbol: ECL
Transactions as of: 13 Nov 2024
Transactions value $: $-248,292
Form type: 4
Filing time: 15 Nov 2024, 16:35:08 UTC
Previous filing: 02 Oct 2024
Next filing: 03 Jan 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ECL	Common Stock	Options Exercise	$251,330	+2,000	+7.63%	$125.66	28,201	13 Nov 2024	Direct
transaction	ECL	Common Stock	Sale	$-499,622	-2,000	-7.09%	$249.81	26,201	13 Nov 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ECL	Non-Employee Stock Option (Right to Buy)	Options Exercise	$0	-2,000	-100%	$0.000000	0	13 Nov 2024	Common Stock	2,000	$125.66	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction was executed in multiple trades at prices ranging from $249.790 to $249.830, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2	The option became exercisable, on a cumulative basis, as to 25% of the option shares (excluding any fractional portion less than one share), on the last day of each of the first, second and third three-month periods following its date of grant and as to the remaining shares on the last day of the fourth three-month period following its date of grant. The date listed in the "Date Exercisable" column represents the first vesting date.

Content

This transaction was executed in multiple trades at prices ranging from $249.790 to $249.830, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

The option became exercisable, on a cumulative basis, as to 25% of the option shares (excluding any fractional portion less than one share), on the last day of each of the first, second and third three-month periods following its date of grant and as to the remaining shares on the last day of the fourth three-month period following its date of grant. The date listed in the "Date Exercisable" column represents the first vesting date.